Case portfolio

MucoShield AB – A new preventive treatment for chemotherapy induced oral mucositis, with a broader focus on oral health

Mucoshield AB is developing an innovative, locally administered treatment to prevent chemotherapy induced oral mucositis (CIOM), a serious and common condition among cancerpatients. The treatment principle is based on the assumption that temporary modulation of local blood flow in the oral mucosa can reduce tissue exposure to cytotoxic drugs. This protective effect will be evaluated in upcoming studies, with the goal of preventing the development of severe oral mucositis.

RegenCura – Development of scaffold material to support bone regeneration for dental surgery

There is a growing and heterogeneous group of patients who need dental surgery due to diseases or accidents. RegenCura has developed a green, mesoporous scaffold material with superior osteogenic properties compared to other commercial products.

Nil Medical – offers increased mobility for children undergoing avanced medical treatment

A wish to enable children to move and play even under advanced medical treatment was the starting point for Nil Medical. This mission has now led to their first product, Vestpack, that now is being tested in clinic.

Böse Pharmaceuticals – Selective anti-infectives to address Cryptosporidium infection

We have developed a new class of orally highly active anti-cryptosporidium agents. The product would be the first efficient anti-cryptosporidium therapy on the animal health market.

Shades of Green – Where Moss Cultivation Meets Architecture and Eco-Innovation

Shades of Green, led by Daniel Pacurar of Boreal Orchards, is developing innovative approaches for sustainable and adaptive greening solutions both for urban environments and for restoring disturbed ecosystems. The aim is to create moss-coated solutions for outdoor and indoor spaces that are both functional and aesthetic.

Neores – Improving neonatal resuscitation and ventilation

Neores mission is to improve neonatal ventilation to save more preterm infants from death and comorbidities. Their work in this field has led to the development of rPAP, the first novel resuscitation system in more than 30 years.

Development of a small chemical compound to target Epstein-Barr Virus associated diseases

Cropcision – Precision fertilizer technology for farms, forests and greenhouses

Food security can no longer rest on a bedrock of wasteful, fossil fuel-based fertilizer that create the environmental risk of leaching into aquatic ecosystems and causing eutrophication. Cropcision offers a step-change enhancement in fertilizer efficiency.

Phenotype Diagnostics – Novel method for risk assessment and treatment stratification in men with prostate cancer

Prostate cancer (PC) is a common and multifocal disease, with symptoms ranging from harmless to lethal. In Sweden, about 10000 new cases are diagnosed every year.

Mucocort – Oral patch for instant pain relief and faster healing of Recurrent Apthous Ulcers (RAS)

Recurrent aphthous ulcers (RAS) are mouth ulcers that can last for more than a week at each occasion and during that period patients often suffer and need sick leave. About 80% of all patient’s state that the pain from RAS is the main symptom. The innovative oral patch (MO45A) shields the ulcer giving instant pain relief and improves healing primarily through it´s extensive hygroscopic effect.

New insecticides for control of disease-transmitting mosquitos

We are developing safe and resistance-breaking molecules that target an enzyme essential for nerve signaling in mosquitoes via a new mode of action. In contrast to current insecticides, we have designed our molecules to specifically target mosquitoes, without affecting other organisms.